Literature DB >> 8612026

Wegener's granulomatosis--increased incidence or increased recognition?

D M Carruthers1, R A Watts, D P Symmons, D G Scott.   

Abstract

We aimed to calculate the annual incidence of Wegener's granulomatosis (WG) in Norfolk (UK) and to compare the clinical spectrum of disease to that seen in tertiary centres in both the UK and USA. We also aimed to examine the seasonal onset of symptoms. This was a prospective study of all patients presenting with WG to a district hospital with a well-defined stable population (515,000) during the period 1988-1993. The annual incidence for WG in the adult population is 8.5/million (95% CI 5.2-12.9). These are the first incidence figures for a well-defined population and are higher than previously published. The clinical spectrum of disease in Norfolk was similar to that seen in tertiary centres and there is supportive evidence for a seasonal variation in the onset of symptoms (highest in winter).

Entities:  

Mesh:

Year:  1996        PMID: 8612026     DOI: 10.1093/rheumatology/35.2.142

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  12 in total

1.  Systemic vasculitis: epidemiology, classification and environmental factors.

Authors:  D G Scott; R A Watts
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

2.  Bilateral central retinal artery occlusion in Wegener's granulomatosis and alpha(1) antitrypsin deficiency.

Authors:  S C Wong; R L Boyce; T C Dowd; J N Fordham
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

3.  Demographics and environmental factors in a Wegener's granulomatosis cluster.

Authors:  J H M Lee; T Attygalle; K Gaffney; D G I Scott
Journal:  Ann Rheum Dis       Date:  2007-02       Impact factor: 19.103

4.  Immunoglobulin (Ig)M antibodies to proteinase 3 in granulomatosis with polyangiitis and microscopic polyangiitis.

Authors:  J M Clain; A M Hummel; J H Stone; F C Fervenza; G S Hoffman; C G M Kallenberg; C A Langford; W J McCune; P A Merkel; P A Monach; P Seo; R F Spiera; E W St Clair; S R Ytterberg; U Specks
Journal:  Clin Exp Immunol       Date:  2017-02-07       Impact factor: 4.330

5.  The expression of Toll-like receptors 2, 4 and 9 in kidneys of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.

Authors:  H Wang; S-J Gou; M-H Zhao; M Chen
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

6.  Stable incidence of systemic vasculitides in schleswig-holstein, Germany.

Authors:  Karen Herlyn; Bernhard Hellmich; Wolfgang L Gross; Eva Reinhold-Keller
Journal:  Dtsch Arztebl Int       Date:  2008-05-09       Impact factor: 5.594

Review 7.  The immunopathology of ANCA-associated vasculitis.

Authors:  Eoin F McKinney; Lisa C Willcocks; Verena Broecker; Kenneth G C Smith
Journal:  Semin Immunopathol       Date:  2014-07-24       Impact factor: 9.623

8.  Seasonal variations in the onset of positive and negative renal ANCA-associated vasculitis in Spain.

Authors:  Juliana Draibe; Xavier Rodó; Xavier Fulladosa; Laura Martínez-Valenzuela; Montserrat Diaz-Encarnación; Lara Santos; Helena Marco; Luis Quintana; Eva Rodriguez; Xoana Barros; Rosa Garcia; Anna Balius; Josep M Cruzado; Joan Torras
Journal:  Clin Kidney J       Date:  2017-12-02

9.  Temporal and Cartographic Analyses of the Distribution within Spain of Mortality Due to Granulomatosis with Polyangiitis (1984⁻2016).

Authors:  Germán Sánchez-Díaz; Francisco Escobar; Ana Villaverde-Hueso; Manuel Posada de la Paz; Verónica Alonso-Ferreira
Journal:  Int J Environ Res Public Health       Date:  2019-04-17       Impact factor: 3.390

10.  Farm Exposure as a Differential Risk Factor in ANCA-Associated Vasculitis.

Authors:  P Willeke; B Schlüter; C Sauerland; H Becker; S Reuter; A Jacobi; H Schotte
Journal:  PLoS One       Date:  2015-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.